Begüm Irmak Ön - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Multiple Sclerosis and Related Disorders|December 29, 2024

Multivariable prognostic prediction of efficacy and safety outcomes and response to fingolimod in people with relapsing-remitting multiple sclerosisBegüm Irmak Ön, Joachim Havla, Ulrich Mansmann

Plos One|December 26, 2025

Individual-level surrogacy of MRI lesions for disease severity in RRMS: Methods to quantify predictive power and their application to longitudinal data from recent trialsStefan Buchka, Joachim Havla, Begüm Irmak Ön, et al.

European Journal of Neurology|October 11, 2021

Antidepressant use and stroke or mortality risk in the elderlyBegüm Irmak Ön, Xavier Vidal, Ursula Berger, et al.

Therapeutic Advances in Neurological Disorders|November 24, 2025

External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort studyStefan Buchka, Alexander Hapfelmeier, Jan S Kirschke, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Multiple Sclerosis and Related Disorders|December 29, 2024

Multivariable prognostic prediction of efficacy and safety outcomes and response to fingolimod in people with relapsing-remitting multiple sclerosisBegüm Irmak Ön, Joachim Havla, Ulrich Mansmann

Plos One|December 26, 2025

Individual-level surrogacy of MRI lesions for disease severity in RRMS: Methods to quantify predictive power and their application to longitudinal data from recent trialsStefan Buchka, Joachim Havla, Begüm Irmak Ön, et al.

European Journal of Neurology|October 11, 2021

Antidepressant use and stroke or mortality risk in the elderlyBegüm Irmak Ön, Xavier Vidal, Ursula Berger, et al.

Therapeutic Advances in Neurological Disorders|November 24, 2025

External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort studyStefan Buchka, Alexander Hapfelmeier, Jan S Kirschke, et al.

Pageof 1